This report presents a demand-based quantitative forecast that pinpoints areas of opportunity in this field.!--h2>
Enal Razvi, Ph.D.
The focus of this GEN Market & Tech Analysis Report is to present the market segmentation and quantitative landscape for growth factors as they are currently utilized for cell culture in various application spaces. We've characterized the marketplace based on telephone interviews as surveys of researchers around the world, and based on this bottom-up analysis we've identified the top growth factors that are currently utilized in the research environment. This analysis frames the market opportunity for various classes of growth factors and frames the market segments into which this opportunity can be assigned.
Highlights of this report:
We’ve characterized from the bottom-up the market landscape of growth factors for cell culture of important cellular classes such as stem cells.
The analysis identifies the top classes of growth factors as well as presents the penetration of many different growth factors in the research market.
The significance of this analysis is that it offers a demand-based quantitative forecast and pinpoints areas of opportunity.
One important space where growth factors and media supplements will be utilized in the future is stem cell growth and expansion especially in the context of cellular therapy going forward—it is therefore important to provide granularity on this field especially as it relates to raw materials required and cost of stem cell production en masse.
Enal Razvi, Ph.D., conducted his doctoral work on viral immunology and subsequent to receiving his Ph.D. went on to the Rockefeller University in New York to serve as Aaron Diamond Post-doctoral fellow under Professor Ralph Steinman [Nobel Prize Winner in 2011 for his discovery of dendritic cells in the early-70s with Zanvil Cohn]. Subsequently, Dr. Razvi completed his research fellowship at Harvard Medical School. For the last two decades Dr. Razvi has worked with small and large companies and consulted for more than 100 clients worldwide. He currently serves as Biotechnology Analyst and Managing Director of SelectBio U.S. He can be reached at email@example.com.